Skip to content
Riskpilot
← Back to search
Sign in
Get full access
NOVO NORDISK PHARMA OPERATIONS A/S
A/S
Active
CVR 32657222
Novo Alle 1, 2880
Bagsværd
Intermediation service activities for specialised construction services
· NACE 4360
Est. 2009
— employees
Watchlist
Share
Denmark
/
Companies
/
Intermediation service activities for specialised construction services
/
NOVO NORDISK PHARMA OPERATIONS A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (4)
CS
Claus Steensen Sølje
Chief Executive Officer
Chief Executive Officer
2013 – 2017
PH
Peter Helt Jacobsen Haahr
Management
Management
2010 – 2013
LB
Lars Bo Smidt
Chief Executive Officer
Chief Executive Officer
2017 – 2020
LF
Leif Fenger Jensen
Management
Management
2009 – 2010
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
LB
Lars Bo Smidt
Board of Directors
2023
LT
Linette Tangsgaard Nielsen
Board of Directors
2020
JF
John Francis Kuckelman
Chairman
2024
Former (8)
LM
Lene Moth Bang
Board of Directors
2018 – 2020
OF
Ole Falvig Ramsby
Chairman
2009 – 2018
KA
Kristine Aachmann Bethe
Chairman
2023 – 2024
LG
Lars Green
Board of Directors
2009 – 2014
KM
Karsten Munk Knudsen
Board of Directors
2014 – 2018
TH
Tomas Haagen
Chairman
2018 – 2023
AM
Anne Mette Wiis Vogelsang
Board of Directors
2015 – 2017
RJ
Robert Janicki
Board of Directors
2009 – 2015
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NOVO NORDISK REGION AAMEO AND LATAM A/S
Company
100%
100%
2009
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NOVO NORDISK PHARMA OPERATIONS A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network